Bladder News and Research

RSS

Naturally occurring protein shows promise as biocontrol weapon against schistosomiasis

A naturally occurring protein has been discovered that shows promise as a biocontrol weapon against schistosomiasis, one of the world's most prevalent parasitic diseases, Oregon State University researchers reported today in a new study.

15 Feb 2017

Drug given to reduce side effects of pain medication may facilitate gastrointestinal recovery after testicular cancer surgery

Post-operative recovery and length of hospital stay are critical things to consider when having major surgery. A drug commonly given to reduce the side effects of strong post-surgery pain medications has been found to reduce the length of hospital stays for patients who have undergone major gastrointestinal or bladder cancer procedures.

15 Feb 2017

Researchers discover new culture method that unlocks natural fighter function of immune T cells

Mayo Clinic and University of Washington researchers have discovered a new culture method that unlocks the natural fighter function of immune T cells when they are passing through the bloodstream.

14 Feb 2017

Study finds limited evidence that styrene causes cancer in humans

In 2011, the styrene, a high volume plastics chemical and animal carcinogen, was the focal point in a 'poison scandal' in the Danish media; but now a registry study of more than 72,000 employees from more than 400 companies that have been exposed to styrene during production of glassfibre reinforced plastics, has not found an increased incidence of a wide range of cancer types.

14 Feb 2017

Testing for circulating tumour cells could help predict bladder cancer patients’ prognosis

New research indicates that about one-quarter of patients with bladder cancer treated with radical surgery on curative intent have detectable levels of tumour cells circulating in their blood.

13 Feb 2017

New drug offers hope for patients with bladder cancer

A bladder cancer drug discovered and developed at The University of Kansas Cancer Center is set to become its first cancer drug to go from bench to bedside.

10 Feb 2017

Scientists show how immune receptor activated by bacteria contributes to diabetic bladder dysfunction

Bladder dysfunction is a reality for about half of patients with diabetes and now scientists have evidence that an immune system receptor that's more typically activated by bacteria is a major contributor.

7 Feb 2017

More than 1,000 patients at Sheffield Teaching Hospitals benefit from high-tech robot

More than 1,000 patients at Sheffield Teaching Hospitals have now benefitted from a high-tech robot that enables surgeons to perform highly precise and minimally-invasive surgery.

1 Feb 2017

New immunotherapy active against mucosal melanoma and improves survival for bladder cancer patients

Clinical trials of a new immunotherapy, pembrolizumab, have shown that it prolongs life significantly for patients with bladder cancer and is active against a rare sub-type of melanoma, called mucosal melanoma.

30 Jan 2017

Human cells integrated into pig and cow embryos

Scientists have shown for the first time that undifferentiated human stem cells can be integrated into early embryos of both pigs and cattle. The construction of such interspecies embryos may represent an important development in the generation of organs for transplant.

27 Jan 2017

Researcher to explore experiences of teenage girls living with endometriosis

A researcher from Birmingham City University is set to embark on a study into the awareness and experiences of endometriosis in adolescent girls

18 Jan 2017

Study compares two common treatment options for pelvic organ prolapse

Pelvic organ prolapse occurs when the pelvic organs drop from their normal position in the pelvis.

12 Jan 2017

Mediplus develops new silicone pessaries that eliminate clinical risks associated with surgical mesh

Women who suffer from incontinence or pelvic organ prolapse from obesity, heavy lifting, smoking, chronic constipation or childbirth don’t always need surgery according to a pioneering British medical device manufacturer.

12 Jan 2017

Okayama University researchers uncover potential new therapeutic target for invasive bladder cancer

Researchers at Okayama University have uncovered a potential new therapeutic target for invasive bladder cancer. The GTP hydrolysing enzyme (GTPase), called Dynamin2, facilitates the rapid invasion of cancer into surrounding tissues; inhibiting its activity could limit the progression of bladder cancer.

10 Jan 2017

Cancers acquire resistance to immunotherapy by eliminating tumor-specific genetic mutations

Results of an initial study of tumors from patients with lung cancer or head and neck cancer suggest that the widespread acquired resistance to immunotherapy drugs known as checkpoint inhibitors may be due to the elimination of certain genetic mutations needed to enable the immune system to recognize and attack malignant cells.

6 Jan 2017

New report reveals 25% drop in overall cancer death rate in the U.S.

A steady decline over more than two decades has resulted in a 25% drop in the overall cancer death rate in the United States. The drop equates to 2.1 million fewer cancer deaths between 1991 and 2014.

5 Jan 2017

New TSRI study shows how Piezo2 protein plays critical role in sensing lung expansion

The new study might help shed light on sudden infant death syndrome (SIDS) in human babies, which is thought to be associated with dysfunctional airway sensory neurons.

22 Dec 2016

Study shows effectiveness of pelvic floor muscle training for prevention of prolapse symptoms

Researchers, including several University of Otago academics, have conducted the first trial of pelvic floor muscle training for the prevention of prolapse symptoms in women with early signs of prolapse several years after childbirth, publishing their findings in the world's leading medical journal The Lancet.

21 Dec 2016

Surgery within first two weeks after diagnosis increases risk of death for some endometrial cancer patients

Delaying surgery after a diagnosis of uterine cancer can increase a women's risk of death, but operating too soon can be just as detrimental for some, Penn Medicine physicians report in a new study published in the American Journal of Obstetrics and Gynecology.

16 Dec 2016

Pacific Edge announces commercial launch of Cxbladder Monitor in the U.S.

Pacific Edge Limited, a cancer diagnostics company developing and commercializing a suite of non-invasive tests for the detection and management of bladder cancer, announces today the commercial launch of the third product in the Company's Cxbladder family of products, Cxbladder Monitor, in the United States.

15 Dec 2016